CryoLife Takes Step To Wrest Control Of Reluctant Partner Medafor
This article was originally published in The Gray Sheet
Executive Summary
CryoLife's purchase of an 8% equity stake in privately held surgical hemostat maker Medafor on Jan. 13 could be the first step of a hostile takeover